References
1. Lynch TM, Gutmann DH. Neurofibromatosis 1. Neurologic clinics.2002;20(3):841-65.
2. Lobbous, Bernstock, Coffee, et al. An Update on Neurofibromatosis
Type 1-Associated Gliomas. Cancers. 2020;12(1):114. doi:
10.3390/cancers12010114.
3. Tucker T, Friedman JM, Friedrich RE, Wenzel R, Funsterer C, Mautner
VF. Longitudinal study of neurofibromatosis 1 associated plexiform
neurofibromas. Journal of Medical Genetics. 2008;46(2):81-85.
4. Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis
and management of individuals with neurofibromatosis 1. Journal of
Medical Genetics. 2006;44(2):81-88.
5. Ward BA, Gutmann DH. Neurofibromatosis 1: From lab bench to clinic.Pediatric Neurology. 2005;32(4):221-228.
6. Friedman JM. Review Article : Neurofibromatosis 1: Clinical
Manifestations and Diagnostic Criteria. Journal of Child
Neurology. 2002;17(8):548-554.
7. Riccardi VM. Neurofibromatosis: Clinical Heterogeneity. Year
Book Medical Publishers, Inc.; 1982.
8. Lubs MLE, Bauer MS, Formas ME, Djokvik B. Lisch nodules in
Neurofibromatosis Type1. New England Journal of Medicine.1991;324(18).
9. Saxena RC, Saxena S. Lisch spots in neurofibromatosis type 1.Indian J Ophthalmol. 1991;39(4):179-180.
10. Ehigiamusoe FO, Ogbeide E. Neurofibromatosis with pulsating
exophthalmos. Port Harcourt Medical Journal. 2017;11(2):99.
11. Gaonker CH, Mukherjee AK, Pokle M. Involvement of the eye and orbit
in neurofibromatosis type 1. Indian J Ophthalmol. 1992;40:2-4.
12. Lewis RA, Riccardi VM. Von Recklinghausen neurofibromatosis:
Incidece of iris harmatoma. Ophthalmology. 1981;88(4):348 - 354.
13. Kinori M, Hodgson N, Zeid JL. Ophthalmic manifestations in
neurofibromatosis type 1. Survey of Ophthalmology.2018;63(4):518-533.
14. Ferner RE. The neurofibromatoses. Pract Neurol2010;10:82–93.
15. Martuza RL, Eldridge R. Neurofibromatosis 2. New England
Journal of Medicine. 1988;318(11):684-688.
16. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R.
Incidence of Vestibular Schwannoma and Neurofibromatosis 2 in the North
West of England over a 10 year period: higher incidence than previously
thought. Otol Neurotol. 2005;26(1):93-97.
17. Evans DGR, Baser ME, O’Reilly B, et al. Management of the patient
and family with neurofibromatosis 2: a consensus conference statement.British Journal of Neurosurgery. 2005;19(1):5-12.
18. Nimura M. Neurofibromatosis. Rinsho Derma. 1973;15:653–663.
19. Mansukhani SA. Familial Schwannomatosis: A Diagnostic Challenge.Journal of Clinical and Diagnostic Research. 2017.
20. Adeloye A. Coexistence of acromegaly and neurofibromatosis in a
Nigerian. East African medical journal. 1979;56(1):38-39.
21. Ademiluyi SA, Ijaduola TGA. Neurofibromatosis in Nigerian children.J Natl Med Assoc. 1988;80(9):1014-1017.
22. Ademiluyi SA, Sowemimo GO, Oyeneyin JO. Surgical experience in the
management of multiple neurofibromatosis in Nigerians. West
African journal of medicine. 1989;8(1):59-65.
23. Ahmed H, Falope ZF. An unusual association of a rare variant of
Friedreich’s ataxia with type-I neurofibromatosis in a Nigerian Fulani
family: a 5-year follow-up study. West African journal of
medicine. 1999;18(2):133-138.
24. Odebode TO, Afolayon EAO, Adigun IA, Daramola OOM.
Clinicopathological study of neurofibromatosis type 1: an experience in
Nigeria. International journal of dermatology. 2005;44:116-120.
25. Okoromah CN, Adegbola TA, Ojuola OI. Neurofibromatosis with
malignant transformation presenting as an emergency in a Nigerian child:
a case report. The Nigerian postgraduate medical journal.2005;12(1):49-52.
26. Asuquo M, Nwagbara V, Nnoli M, Ashindoitiang J, Ugbem T, Akpan S.
Neurofibrosarcoma: case series in south-south Nigeria.International Journal of Medicine. 2017;5(1):79.
27. Adeleye AO, Okolo CA, Akang EE, Adesina AM. Cerebral pleomorphic
xanthoastrocytoma associated with NF1: an updated review with a rare
atypical case from Africa. Neurosurgical Review.2011;35(3):313-319.
28. Ibrahim A, Asuku ME. Neurofibromatosis. The New England
journal of medicine. 2011;365:21.
29. Isa SE, Akindele S, Daniyam C, Iroezindu M, Agaba A, Agbaji O. An
HIV-1 Infected Patient with Neurofibromatosis Type 1: A Case Report.Nigerian Health Journal. 2012;12(2):52-53.
30. Azeke AT, Imasogie DE. A review of histologically diagnosed
neurofibromatosis; an institution based study spanning a decade.SSRG International Journal of Medical Science 2018;5(6):1-4.
31. Anyabolu EN. Lumbar plexiform neurofibroma, short stature, and
kyphoscoliosis in neurofibromatosis-1: A Rare entity. Sahel
Medical Journal. 2019;22(3):153.
32. Nyandaiti YW, Tahir C, Nggada HA, Ndahi AA. Clinico-pathologic
presentation and management of neurofibromatosis type 1(Von
Recklinghausen’s) disease among north-eastern Nigerians: A six year
review. . Niger Med J. 2009;50:80-83.
33. National Institute of Health (NIH). Neurofibromatosis. NIH Consensus
Statement Online. Vol 6 Online National Institute of Health; 1987:1-19.
34. National Institutes of Health. National Institutes of Health
Consensus Development Conference Statement: neurofibromatosis. Bethesda,
Md., USA, July 13-15, 1987. Neurofibromatosis. 1988;1(3):172-178.
35. Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P,
Wolkenstein P; NF France Network. Neurofibromatosis 1 French national
guidelines based on an extensive literature review since 1966.Orphanet Journal of Rare Diseases. 2020 Feb 3;15(1):37. doi:
10.1186/s13023-020-1310-3.
36. Yusuf A, Pillai A, Menon S, Panikar D. Massive spontaneous
hemothorax, giant intrathoracic meningocele, and kyphoscoliosis in
neurofibromatosis type 1. Journal of Surgical Technique and Case
Report. 2014;6(1):33.
37. Elsayed SM, Fahmy N, Gamal R, et al. Neurofibromatosis type 1 and
multiple sclerosis: Genetically related diseases. Egyptian Journal
of Medical Human Genetics. 2017;18(3):295-298.
38. Boley S, Sloan JL, Pemov A, Stewart DR. A Quantitative Assessment of
the Burden and Distribution of Lisch Nodules in Adults with
Neurofibromatosis Type 1. Investigative Opthalmology & Visual
Science. 2009;50(11):5035-5043.
39. Ragge NK, Falk RE, Cohen WE, Murphree AL. Images of Lisch nodules
across the spectrum. Eye. 1993;7:95-101.
40. Cruciani F, Carmen Piraino D, Albanese G, Rahimi S, Abdolrahimzadeh
B. Neurofibromatosis: an update of ophthalmic characteristics and
applications of optical coherence tomography. Clinical
ophthalmology. 2016:851.
41. Coy S, Rashid R, Stemmer-Rachamimov A, Santagata S. An update on the
CNS manifestations of neurofibromatosis type 2. Acta
Neuropathologica. 2019;139(4):643-665.
42. Fried I, Tabori U, Tihan T, Reginald A, Bouffet E. Optic pathway
gliomas: a review. CNS Oncol 2013;2(2):143–159.
43. Olubunmi OA. Misdiagnosis of tuberous sclerosis in a Nigerian girl:
A case report and review of literature. Ann Afr Med
2010;9:95-101.
44. Elechi EN, Etawa US. Solitary lumbar neurofibroma in a patient with
neurofibromatosis. Tropical doctor. 1994;24(4):174 doi:
10.1177/004947559402400415..
45. Asuquo ME. Neurofibrosarcoma - complicating neurofibromatosis-I:
case report and review of relevant literature. The Nigerian
postgraduate medical journal. 2005;12(3):233-236.
46. Legbo JN, Shehu BB, Malami SA. Malignant peripheral nerve sheath
tumour associated with von Recklinghausen’s disease: case report.East African medical journal. 2005;82(1):47-49.
47. Shehu BB, Hassan I. Cervicothoracic arachnoid cyst in a patient with
neurofibromatosis: case report. East African medical journal.2006;83(9):515-517.
48. Etiuma AO, Bassey OO, Asuquo E, Ebughe G. Multiple
Neurofibrosarcoma. Nig J Surgery. 2007;13(1-2):29-31.
49. Ekpe EE. Malignant transformation in von recklinghausen disease in a
rural farmer presenting as huge metastatic soft tissue chest wall
tumour: a case report. West African journal of medicine.2014;33(1):77-79.
50. Nasir AA. Re: ’Diffuse ganglioneuromatosis and plexiform
neurofibroma of the urinary bladder: an uncommon cause of severe
urological disease in an infant’. J Pediatr Urol. 2013 Apr;
9(3):e131-e133. Journal of pediatric urology. 2014;10(1):198.
51. Yahya H, Sani H. Eruptive neurofibromas in pregnancy. Annals
of African medicine. 2020;19(2):150-152.
52. Mautner VF, Hartmann M, Kluwe L, Friedrich RE, Fünsterer C. MRI
growth patterns of plexiform neurofibromas in patients with
neurofibromatosis type 1. Neuroradiology. 2006;48(3):160-165.
53. Eldridge R, Denckla MB, Bien E, et al. Neurofibromatosis type 1
(Recklinghausen’s disease). Neurologic and cognitive assessment with
sibling controls. American journal of diseases of children.1989;143(7):833-837.
54. Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P,
Wolkenstein P. Neurofibromatosis 1 French national guidelines based on
an extensive literature review since 1966. Orphanet Journal of
Rare Diseases. 2020;15(1).
55. Wolsey DH, Larson SA, Creel D, Hoffman R. Can Screening for Optic
Nerve Gliomas in Patients With Neurofibromatosis Type I Be Performed
With Visual-Evoked Potential Testing? Journal of American
Association for Pediatric Ophthalmology and Strabismus.2006;10(4):307-311.